Stock Track | UltraGreen.ai Soars 3.50% Intraday on Analyst View It's Shielded from Pharma Tariffs

Stock Track
Apr 07

ULTRAGREEN AI USD (ULG.SI) saw its stock price soar by 3.50% during intraday trading on Tuesday.

The surge follows analysis from DBS Group Research suggesting the company is unlikely to be negatively impacted by the Trump administration's decision to impose a 100% tariff on patented pharmaceutical products. The firm's water-soluble, FDA-approved dye used for fluorescence imaging is classified as a generic drug and falls under the current tariff exemption.

Analysts added that demand for the product is expected to remain relatively price-inelastic, and the company should be able to pass on any potential future tariff-related costs to customers. An additional mitigating factor is that UltraGreen.ai's kits for the Americas are packaged in Michigan. DBS maintains its buy rating and a US$2.00 target price for the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10